GLY-230

DRUG2 trials

Sponsors

Glycadia

Conditions

DiabetesDiabetic Nephropathy

Phase 1

Multiple Dose Trial of Anti-glycation Agent GLY-230 in Healthy and Diabetic Subjects

CompletedNCT00544934

GlycadiaDiabetic Nephropathy

Start: 2007-02-28End: 2007-10-31Updated: 2016-02-10

Phase 1 Study of Anti-glycation Agent GLY-230 in Healthy Subjects

CompletedNCT00544921

GlycadiaDiabetes

Start: 2005-10-31End: 2006-10-31Updated: 2016-02-10